Recognizing January 2026 As National Blood Donor Month In The State Of Delaware.
Summary
SCR 128 is a nonbinding concurrent resolution that designates January 2026 as “National Blood Donor Month” in Delaware. The resolution honors voluntary blood donors, highlights the importance of maintaining an adequate and diverse blood supply, and encourages residents to donate blood regularly. It also calls on businesses and organizations to support community blood drives, including efforts with Blood Bank of Delmarva and other blood collection institutions.
The resolution explains why blood donation is especially important: blood transfusions are frequent, only a small share of eligible people donate, and shortages can affect trauma care, surgery, cancer treatment, newborn care, transplant patients, and people with chronic blood disorders. It specifically notes the importance of O-negative blood and low-titer O-positive blood used in emergency and prehospital trauma settings, including by Delaware emergency services and the State Police Aviation Unit.
Impact
SCR 128 does not amend Delaware statutes or create enforceable legal duties; instead, it expresses the General Assembly’s recognition of blood donors and its support for blood donation awareness efforts. Its practical effect is to promote public outreach, encourage blood drives, and reinforce the role of blood collection organizations and emergency medical providers in maintaining the state’s blood supply.
Sentiment
The sentiment around the resolution is strongly supportive and ceremonial. The bill passed the Senate Third Reading unanimously, 20-0, indicating broad bipartisan agreement. The text and vote history suggest little controversy, with lawmakers presenting the measure as a public-health and community-service recognition rather than a policy dispute.
Contention
There is no recorded committee debate or vote opposition, and no substantive points of contention appear in the available materials. The resolution’s only implicit policy emphasis is on encouraging more blood donation and community blood drives, but this is framed as a public-health appeal rather than a contested regulatory issue. The measure is therefore best characterized as consensus-driven and commemorative.